2008
DOI: 10.1016/j.ymgme.2007.12.006
|View full text |Cite
|
Sign up to set email alerts
|

+647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
55
0
1

Year Published

2010
2010
2019
2019

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 76 publications
(58 citation statements)
references
References 42 publications
2
55
0
1
Order By: Relevance
“…A mutation in the IL6 promoter upregulates its expression leading to increased MT, low plasma zinc, impaired innate immunity (Mocchegiani et al 2007), and increased risk of AD (Licastro et al 2003). A mutation in the coding region of MT1A is associated with increased expression of IL6 and MT, higher risk of DM2, and shorter lifespan (Cipriano et al 2006;Giacconi et al 2008). Furthermore, this mutation may directly interfere with the functions of zinc in cellular signal transduction because it attenuates the release of zinc in response to nitric oxide (Cipriano et al 2006).…”
Section: Zinc and Insulin Signaling In Diabetes Mellitus And Dementiamentioning
confidence: 99%
“…A mutation in the IL6 promoter upregulates its expression leading to increased MT, low plasma zinc, impaired innate immunity (Mocchegiani et al 2007), and increased risk of AD (Licastro et al 2003). A mutation in the coding region of MT1A is associated with increased expression of IL6 and MT, higher risk of DM2, and shorter lifespan (Cipriano et al 2006;Giacconi et al 2008). Furthermore, this mutation may directly interfere with the functions of zinc in cellular signal transduction because it attenuates the release of zinc in response to nitric oxide (Cipriano et al 2006).…”
Section: Zinc and Insulin Signaling In Diabetes Mellitus And Dementiamentioning
confidence: 99%
“…Polymorphisms have also been found in MT-1 and MT-2 [Giacconi et al 2008[Giacconi et al , 2005Yang et al 2008]. A polymorphism in MT-1A for example, was associated with type 2 diabetes in patients with cardiovascular complications [Giacconi et al 2008]. Less zinc was released from stimulated blood leucocytes in these patients, suggesting loss of zinc bioavailability.…”
Section: Gene Polymorphisms: Potential Gene-environment Interactionsmentioning
confidence: 99%
“…Importantly, diabetes patients with polymorphisms in the MT gene are more susceptible to the development of various diabetic complications (10,34). We considered that MT protection from diabetes-induced pathological changes might be attributed to its antioxidant function, theorizing that it might reduce nitrosative damage, based on our previously published data showing that diabetic MT-TG mice had significantly less 3-NT accumulation in the heart at 2-4 wk of diabetes (4).…”
Section: Discussionmentioning
confidence: 99%